A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Publication date: Oct 22, 2021 This study will evaluate if relapsing-remitting MS patients that have ...
Multiple Sclerosis
This magazine is directed toward patients with Multiple Sclerosis, their families, care givers, physicians and researchers. The content is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Multiple Sclerosis.
You may filter the results to view only the latest news, media (podcasts and videos) or scientific literature using these buttons.
-
-
Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases
Publication date: Oct 22, 2021 Numerous studies have shown the diagnostic interest of cerebrospinal fluid ... -
Characterizing the Use of Ofatumumab in a Real World Setting
Publication date: Oct 22, 2021 This is a non-interventional primary use of data study utilizing ... -
Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis.
Publication date: Feb 01, 2021 Acute optic neuritis is the most common neuro-opthalmologic manifestation of ... -
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study: Serum NfL predicts relapse-free progression.
Publication date: Sep 24, 2021 Easily accessible biomarkers enabling the identification of those patients with ... -
Multiple sclerosis lesions segmentation from multiple experts: The MICCAI 2016 challenge dataset.
Publication date: Sep 24, 2021 MRI plays a crucial role in multiple sclerosis diagnostic and ... -
Multiple sclerosis lesions segmentation from multiple experts: The MICCAI 2016 challenge dataset.
Publication date: Sep 24, 2021 MRI plays a crucial role in multiple sclerosis diagnostic and ... -
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.
Publication date: Sep 23, 2021 The specificity and implementation of current MRI-based diagnostic criteria for ... -
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.
Publication date: Sep 23, 2021 The specificity and implementation of current MRI-based diagnostic criteria for ... -
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.
Publication date: Sep 23, 2021 The specificity and implementation of current MRI-based diagnostic criteria for ... -
Optic neuritis in Asian type opticospinal multiple sclerosis (OSMS-ON) in a non-Asian population: A functional-structural paradox.
Publication date: Sep 09, 2021 Biomarkers have improved the classification of autoimmune inflammatory disorders, including ... -
[Pharmacoeconomic aspects of using cladribine (in tablets) for treatment of adult patients with remitting multiple sclerosis].
Publication date: Sep 05, 2021 To conduct a pharmacoeconomic analysis of using cladribine (in tablets) ... -
[Pharmacoeconomic aspects of using cladribine (in tablets) for treatment of adult patients with remitting multiple sclerosis].
Publication date: Sep 05, 2021 To conduct a pharmacoeconomic analysis of using cladribine (in tablets) ... -
[Pharmacoeconomic aspects of using cladribine (in tablets) for treatment of adult patients with remitting multiple sclerosis].
Publication date: Sep 05, 2021 To conduct a pharmacoeconomic analysis of using cladribine (in tablets) ... -
Barriers and motivators for tobacco smoking cessation in people with multiple sclerosis.
Publication date: Sep 01, 2021 Smoking is a key modifiable risk factor for health outcomes ... -
Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets – expert opinion on issues in clinical practice.
Publication date: Sep 01, 2021 Oral cladribine is the first oral pulsed therapy licensed for ... -
Economic Evaluation of Cladribine Tablets in Patients With High Disease Activity-Relapsing-Remitting Multiple Sclerosis in the Kingdom of Saudi Arabia.
Publication date: Sep 01, 2021 Cladribine tablets are the first short-course oral treatment approved for ... -
Economic Evaluation of Cladribine Tablets in Patients With High Disease Activity-Relapsing-Remitting Multiple Sclerosis in the Kingdom of Saudi Arabia.
Publication date: Sep 01, 2021 Cladribine tablets are the first short-course oral treatment approved for ... -
Clinical predictors of disease progression in a cohort of Tunisian progressive Multiple Sclerosis.
Publication date: Aug 31, 2021 Knowledge about progressive Multiple Sclerosis (MS) is mainly based on ... -
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study.
Publication date: Sep 26, 2021 The tailored immunomodulatory treatment strategy for secondary progressive multiple sclerosis ... -
Fully automated detection of paramagnetic rims in multiple sclerosis lesions on 3T susceptibility-based MR imaging.
Publication date: Aug 27, 2021 The presence of a paramagnetic rim around a white matter ...